Home › Compare › SCPS vs PLD

SCPS vs PLD: Dividend Comparison 2026

SCPS yields 500000.00% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SCPS wins by $4.663521010693878e+33M in total portfolio value
10 years
SCPS
SCPS
● Live price
500000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.663521010693878e+33M
Annual income
$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00
Full SCPS calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — SCPS vs PLD

📍 SCPS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSCPSPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SCPS + PLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SCPS pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCPS
Annual income on $10K today (after 15% tax)
$42,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, SCPS beats the other by $3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCPS + PLD for your $10,000?

SCPS: 50%PLD: 50%
100% PLD50/50100% SCPS
Portfolio after 10yr
$2.331760505346939e+33M
Annual income
$2,330,843,480,963,498,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

SCPS
No analyst data
Altman Z
-250.9
Piotroski
1/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCPS buys
0
PLD buys
0
No recent congressional trades found for SCPS or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSCPSPLD
Forward yield500000.00% ✓3.18%
Annual dividend / share$2.00$4.10 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4% ✓
Portfolio after 10y$4.663521010693878e+33M$6.50M ✓
Annual income after 10y$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00 ✓$5,256,436.18
Total dividends collected$4.6634009849658873e+33M$6.37M ✓
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: SCPS vs PLD ($10,000, DRIP)

YearSCPS PortfolioSCPS Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$50,010,700$50,000,000.00$11,255$555.24+$50.00M → SCPS
2$233,748,371,262$233,694,859,813.08$13,062$1,018.59+$233748.36M → SCPS
3$1,021,074,511,412,696$1,020,824,400,655,446.10$15,903$1,926.67+$1021074511.40M → SCPS
4$4,168,597,328,794,951,700$4,167,504,779,067,739,000.00$20,839$3,823.32+$4168597328794.93M → SCPS
5$15,905,475,114,600,665,000,000$15,901,014,715,458,854,000,000.00$30,464$8,166.08+$15905475114600664.00M → SCPS
6$56,718,938,532,531,060,000,000,000$56,701,919,674,158,435,000,000,000.00$52,054$19,457.30+$56718938532531060736.00M → SCPS
7$189,031,807,435,623,860,000,000,000,000$188,971,118,171,394,040,000,000,000,000.00$109,886$54,188.93+$1.8903180743562385e+23M → SCPS
8$588,799,810,476,518,260,000,000,000,000,000$588,597,546,442,562,100,000,000,000,000,000.00$304,030$186,451.18+$5.8879981047651824e+26M → SCPS
9$1,714,064,268,114,722,600,000,000,000,000,000,000$1,713,434,252,317,512,700,000,000,000,000,000,000.00$1,166,125$840,813.32+$1.7140642681147225e+30M → SCPS
10$4,663,521,010,693,878,300,000,000,000,000,000,000,000$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$6,504,190$5,256,436.18+$4.663521010693878e+33M → SCPS

SCPS vs PLD: Complete Analysis 2026

SCPS — Stock

Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) inhibitors; and MRI-1867, rationally designed, orally available, dual-action, hybrid, and small molecule that is an inverse agonist of the endocannabinoid system/cannabinoid receptor 1, as well as an inhibitor of inducible nitric oxide synthase. Scopus BioPharma Inc. has strategic partnerships with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem for its lead development and other programs. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York.

Full SCPS Calculator →

PLD — REIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this SCPS vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCPS vs SCHDSCPS vs JEPISCPS vs OSCPS vs KOSCPS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.